I'm with Perrier. I've seen so many businesses get carried away and overreach their expertise, and come down to earth will a hell of a crash. Neuren has a fantastic product, but they are innovators, not industrialists. If these treatments are to be made available to the people who need them. then Neuren needs to step back and leave the future to those with the expertise and connections to take these amazing products to their optimum. Whether that is through a partnership or a takeover doesn't matter, but I really think that stepping away and letting the experts take over will have the most beneficial outcome for both patients and shareholders. It's been a great ride, and I applaud everyone from Dame Margaret Brimble upwards, but it's time to step back and let others take this to the stars.
Share Price, page-8486
-
- There are more pages in this discussion • 2,232 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.00 |
Change
0.090(0.45%) |
Mkt cap ! $2.556B | |||
| Open | High | Low | Value | Volume |
| $19.88 | $20.07 | $19.73 | $11.80M | 591.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5901 | $19.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.00 | 3262 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |